New insights into role of microenvironment in multiple myeloma.
Tricot
G
G
Arkansas Cancer Research Center, Little Rock 72205, USA.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002352:Carrier Proteins / Q000378:metabolism; D016207:Cytokines / Q000378:metabolism; D004164:Diphosphonates / Q000627:therapeutic use; D006023:Glycoproteins / Q000378:metabolism; D006801:Humans; D008562:Membrane Glycoproteins / Q000378:metabolism; D009101:Multiple Myeloma / Q000188:drug therapy / Q000276:immunology / Q000473:pathology; D053244:Osteoprotegerin; D000077268:Pamidronate; D053245:RANK Ligand; D053246:Receptor Activator of Nuclear Factor-kappa B; D018160:Receptors, Cytoplasmic and Nuclear; D018124:Receptors, Tumor Necrosis Factor / Q000378:metabolism
D000970:Antineoplastic Agents; D002352:Carrier Proteins; D016207:Cytokines; D004164:Diphosphonates; D006023:Glycoproteins; D008562:Membrane Glycoproteins; D053244:Osteoprotegerin; D053245:RANK Ligand; D053246:Receptor Activator of Nuclear Factor-kappa B; D018160:Receptors, Cytoplasmic and Nuclear; D018124:Receptors, Tumor Necrosis Factor; C505686:TNFRSF11A protein, human; C506030:TNFRSF11B protein, human; C505688:TNFSF11 protein, human; D000077268:Pamidronate